Schrodinger: results of operations

Form 8-K filed Nov 4, 2026 · items 2.02, 7.01

Results of operationsSchrödinger Reports Third Quarter 2026 Financial Results

What the filing says

Schrödinger Reports Third Quarter 2026 Financial Results Third Quarter ACV of $45 Million, Representing 17% Growth

ScaleThe filing names $45.0M: about 17% of Schrodinger's annual revenue ($258.0M, four times the latest quarter).

Read the filing on SEC EDGAR →

What usually followsAcross 69,115 8-Ks reporting Item 2.02 (results of operations) in our universe, the stock's median move the next session was +0.2% (typical size ±3.6%, up 51% of the time); over the following 21 sessions, +1.2%. Every item ranked →

Schrodinger at a glance

Latest quarterQ3 2026

Revenue$64.5M

Revenue Y/Y+19%

Operating margin-40.5%

IndustryPharmaceutical Preparations

Schrodinger, Q3 2026: revenue $64.5M (+19% year over year), operating margin -40.5%. The chart follows the revenue to costs, profit and cash.

Schrodinger: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent guidance

Airsculpt Technologies Nov 6, 2026
Terawulf Nov 6, 2026
Plains GP Holdings LP Nov 6, 2026
PSQ Holdings Nov 6, 2026
Plains All American Pipeline LP Nov 6, 2026
Concentra Group Holdings Parent Nov 5, 2026
Conduent Nov 5, 2026
Teads Holding Nov 5, 2026
iSpecimen Nov 5, 2026
Nano Dimension Nov 5, 2026

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.